Status:
NOT_YET_RECRUITING
T Cell Profiling in Patients with Multiple Sclerosis
Lead Sponsor:
Boston Children's Hospital
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
13-20 years
Brief Summary
The goal of this research study is to to learn more about the body's immune response in patients with multiple sclerosis (MS). In MS, the body's immune cells mistakenly attack an important part of the...
Eligibility Criteria
Inclusion
- MS Group Inclusion criteria
- diagnosis of multiple sclerosis and present to the neurology clinic for a regular checkup or are admitted to the inpatient floor with acute symptoms.
- Exclusion criteria
- Have an active infection
- Take T cell modulating drugs
- Control Group Inclusion criteria -scheduled for elective surgery
- without any immunological diseases. Exclusion criteria
- Have an active infection.
Exclusion
Key Trial Info
Start Date :
June 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04789551
Start Date
June 1 2025
End Date
December 1 2025
Last Update
March 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Children's Hopsital
Boston, Massachusetts, United States, 02115